Search

everythinglearnresearchcommunity

for

Search:↓

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Effective symptom management in IBD improves quality of life and prevents complications.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

Finasteride helps treat frontal fibrosing alopecia, improving or stabilizing the condition in many patients.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.

Radiotherapy can cause various side effects, but symptoms improve after treatment, and staff protection is crucial.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

Many patients on methotrexate experience significant side effects but still continue the medication.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Selenium therapy improved health in cystic fibrosis patients with fewer side effects at a lower dose.

Avacopan may cause unexpected side effects, so early monitoring is important.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.

Losartan may help treat Postural Orthostatic Tachycardia Syndrome (POTS) symptoms.

Biobran MGN-3 reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Taking the same medication under different brand names caused harmful side effects.